The VAP Lipid Panel is the first comprehensive lipid profile to comply with guidelines (NCEP/ATP III, AACE, and ADA/ACC). Guidelines recommend a comprehensive approach to risk stratification1-3. It is the test of choice for accurate, global cardiometabolic risk stratification and management and provides comprehensive lipid analysis. It
simultaneously and accurately measures cholesterol concentrations of all 5 lipoprotein classes and their subclasses in a non-fasting patient4 and clarifies risk and drives a personalized treatment approach based on 3 categories of residual cardiometabolic risk. Directly measures LDL and HDL, providing accurate results in a non-fasting patient. Also measures subclasses including apoB, which reflects atherogenic load.
It Identifies triglyceride-rich disorders, including non-HDL, even in patients with seemingly normal triglyceride levels and Lp(a), a hereditary marker of risk.
Product URL : http://www.atherotech.com/VapCholTest/default.asp
Last Updated : 07/15/2014